Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Mar 2022 for Impel Neuropharma INC, €44k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Stephen B. Shrewsbury: trading record in brief
Filings by Stephen B. Shrewsbury span 2 companies, the busiest being Impel Neuropharma Inc and Sarepta Therapeutics, Inc. The record holds 5 filings, for trades running from 26 January 2009 to 29 March 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 30 March 2022 with an option exercise (€44k) in Impel Neuropharma Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stephen B. Shrewsbury
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
24,606 shares@ US$1.9763.8% of flowCommon StockSEC:0001209191-22-021673:0
14,780 shares@ US$1.9736.2% of flowCommon StockSEC:0001209191-21-057275:0
2 of 2 declarations
